Procedure Standards

The procedure standards help to identify those elements of the procedure that are most important in obtaining a high-quality examination, while simultaneously controlling costs. Use of procedure standards will increase the applicability of clinical research among multiple institutions, in turn, increasing the value of research studies, particularly in the field of technology assessment. In the interest of creating strong, comprehensive documents, some standards were formally adopted by SNMMI in collaboration with other professional organizations.

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) Practice Guidelines were renamed Procedure Standards in February 2014. This change was initiated in an effort to better reflect the terminology being used by external organizations. Any previous Practice Guideline or Procedure Guideline that describes how to perform a procedure is now considered an SNMMI Procedure Standard.

Comments or Questions?

The SNMMI Committee on Procedure Standards is continually developing new standards and reviewing and updating existing procedure standards. If you have specific comments or questions on the content of any of the standards, or if you have suggestions for new standards that you feel should be written, please contact the SNMMI Committee on Procedure Standards here. All comments will be considered in the procedure standards development process.

_
Data pager
Data pager
Page size:
PageSizeComboBox
select
 86 items in 9 pages
Show all 86
The purpose of this document is to guide nuclear medicine practitioners in making recommendations, performing, interpreting, and reporting results of PET imaging of the brain using 2-[18F]fluoro-2-deoxy-D-glucose ([18F]FDG).
Status: Approved
Subject: Central Nervous System
Jun 07, 2024
6/7/2024 8:56:00 AM
This guideline provides general information about indications and protocols for hybrid [18F]FDG PET imaging in inflammation and infection in the adult population.
Status: Approved
Subject: Infection and Inflammation
Jun 07, 2024
6/7/2024 12:00:00 AM
This document describes the appropriate doses for radiopharmaceutical administration in the pediatric population. These recommendations should be utilized to safely guide nuclear medicine physicians in the amount of administered activity being ordere
Status: Approved
Subject: Pediatric
Jun 07, 2024
6/7/2024 12:00:00 AM
Bone scintigraphy is one of the most common functional imaging procedures performed in a nuclear medicine department. It is a sensitive diagnostic test for detection of both benign and malignant osseous abnormalities. Radionuclide bone scans can dete
Status: Approved
Subject: Skeletal System
Dec 08, 2023
12/8/2023 12:00:00 AM
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) is an international scientifc and professional organization founded in 1954 to promote the science, technology, and practical application of nuclear medicine. The EuropeanAssociation of N
Status: Approved
Subject: Oncology
Aug 25, 2023
8/25/2023 8:40:00 PM
The aim of this joint EANM/SNMMI/IHPBA procedure guideline is to provide general information and specific recommendations and considerations on the use of [99mTc]Tc-mebrofenin hepatobiliary scintigraphy (HBS) in the quantitative assessment and risk a
Status: Approved
Subject: Gastrointestinal System
Jul 04, 2023
7/4/2023 12:00:00 AM
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) is an international scientific and professional organization founded in 1954 to promote the science, technology, and practical application of nuclear medicine. Its 15,000 members are physi
Status: Approved
Subject: Endocrine System, Oncology
Jun 23, 2023
6/23/2023 8:59:00 PM
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) is an international scientific and professional organization founded in 1954 to promote the science, technology, and practical application of nuclear medicine. The European Association of
Status: Approved
Subject: Skeletal System
Jun 14, 2023
6/14/2023 12:00:00 AM
Prostate-specifc membrane antigen (PSMA) is expressed by the majority of clinically signifcant prostate adenocarcinomas, and patients with target-positive disease can easily be identifed by PSMA PET imaging. Promising results with PSMA-targeted radio
Status: Approved
Subject: Genitourinary System
Jan 27, 2023
1/27/2023 12:00:00 AM
Here we aim to provide updated guidance and standards for the indication, acquisition, and interpretation of PSMA PET/ CT for prostate cancer imaging. Procedures and characteristics are reported for a variety of available PSMA small radioligands. Dif
Status: Approved
Subject: Genitourinary System
Jan 09, 2023
1/9/2023 12:00:00 AM